Taysha Gene Therapies
TSHA
#7821
Rank
A$0.40 B
Marketcap
$1.99
Share price
-10.59%
Change (1 day)
-54.31%
Change (1 year)

Taysha Gene Therapies (TSHA) - Cash on Hand

Cash on Hand as of December 2024 : A$0.22 Billion

According to Taysha Gene Therapies's latest financial reports the company has A$0.22 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Taysha Gene Therapies - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.22 B5.8%
2023-12-31A$0.21 B63.6%
2022-12-31A$0.12 B-37.21%
2021-12-31A$0.20 B-37.06%
2020-12-31A$0.32 B
2019-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.40 B 84.10%๐Ÿ‡บ๐Ÿ‡ธ USA